PD123319 Augments Angiotensin II-Induced Abdominal Aortic Aneurysms through an AT2 Receptor-Independent Mechanism

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Daugherty, Alan ^a,b   Rateri, Debra L ^a   Howatt, Deborah A ^a   Charnigo, Richard ^c   Cassis, Lisa A ^b,d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c Department of Biostatistics ^*  (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; LOW DENSITY LIPOPROTEIN RECEPTOR; SATURATED FATTY ACID; SODIUM CHLORIDE;

ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; GENOTYPE; LIPID DIET; MALE; MOUSE; NONHUMAN; PROTEIN DEFICIENCY; SYSTOLIC BLOOD PRESSURE; THORACIC AORTA ANEURYSM; WILD TYPE;

ANGIOTENSIN II; ANIMALS; AORTA; AORTA, THORACIC; AORTIC ANEURYSM, ABDOMINAL; ATHEROSCLEROSIS; GENOTYPE; IMIDAZOLES; MALE; MICE; MICE, INBRED C57BL; PYRIDINES; RECEPTOR, ANGIOTENSIN, TYPE 2;

MUS;

EID: 84876074729     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061849     Document Type: Article

References (42)

1. Daugherty A, Manning MW, Cassis LA, (2000) Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 105: 1605-1612.
2. Daugherty A, Cassis L, (1999) Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor -/- mice. Ann NY Acad Sci 892: 108-118.
3. Daugherty A, Rateri DL, Charo IF, Owens AP, Howatt DA, et al. (2010) Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice. Clin Sci (Lond) 118: 681-689.
4. Rateri DL, Moorleghen JJ, Balakrishnan A, Owens AP 3rd, Howatt DA et al (2011) Endothelial cell-specific deficiency of Ang II type 1a receptors attenuates Ang II-induced ascending aortic aneurysms in LDL receptor-/- mice. Circ Res 108: 574-581.
5. Carey RM, Wang ZQ, Siragy HM, (2000) Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function. Hypertension 35: 155-163.
6. Daugherty A, Manning MW, Cassis LA, (2001) Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br J Pharmacol 134: 865-870.
7. Cassis LA, Rateri DL, Lu H, Daugherty A, (2007) Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms. Arterioscler Thromb Vasc Biol 27: 380-386.
8. Akishita M, Iwai M, Wu L, Zhang L, Ouchi Y, et al. (2000) Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice. Circulation 102: 1684-1679.
9. Akishita M, Yamada H, Dzau VJ, Horiuchi M, (1999) Increased vasoconstrictor response of the mouse lacking angiotensin II type 2 receptor. Biochem Biophys Res Commun 261: 345-339.
10. Tanaka M, Tsuchida S, Imai T, Fujii N, Miyazaki H, et al. (1999) Vascular response to angiotensin II is exaggerated through an upregulation of AT1 receptor in AT2 knockout mice. Biochem Biophys Res Commun 258: 194-188.
11. Daugherty A, Rateri DL, Lu H, Inagami T, Cassis LA, (2004) Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation 110: 3849-3857.
12. Johansson ME, Wickman A, Fitzgerald SM, Gan LM, Bergstrom G, (2005) Angiotensin II, type 2 receptor is not involved in the angiotensin II-mediated pro-atherogenic process in ApoE-/- mice. J Hypertens 23: 1541-1549.
13. Iwai M, Chen R, Li Z, Shiuchi T, Suzuki J, et al. (2005) Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice. Circulation 112: 1636-1643.
14. Sales VL, Sukhova GK, Lopez-Ilasaca MA, Libby P, Dzau VJ, et al. (2005) Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution. Circulation 112: 3328-3336.
15. Koitka A, Cao Z, Koh P, Watson AM, Sourris KC, et al. (2010) Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes. Diabetologia 53: 584-592.
16. Tiyerili V, Mueller CF, Becher UM, Czech T, van Eickels M, et al. (2012) Stimulation of the AT2 receptor reduced atherogenesis in ApoE(-/-)/AT1A(-/-) double knockout mice. J Mol Cell Cardiol 52: 630-637.
17. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK, (1995) Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 377: 744-747.
18. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, et al. (1995) Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377: 748-750.
19. Henriques TA, Huang J, D'Souza SS, Daugherty A, Cassis LA, (2004) Orchidectomy, but not ovariectomy, regulates angiotensin II-induced vascular diseases in apolipoprotein E-deficient mice. Endocrinology 145: 3866-3872.
20. Daugherty A, Rateri DL, (1994) Presence of LDL receptor-related protein/alpha 2-macroglobulin receptors in macrophages of atherosclerotic lesions from cholesterol- fed New Zealand and heterozygous Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb 14: 2017-2024.
21. Daugherty A, Rateri D, Lu H, Balakrishnan A (2009) Measuring blood pressure in mice using volume pressure recording, a tail-cuff method. J Vis Exp 1291.
22. Wang YX, Cassis LA, Daugherty A (2006) Angiotensin II-induced abdominal aortic aneurysms. A Handbook of Mouse Models for Cardiovascular Disease Ed. Q. Xu, John Wiley & Sons: 125-136.
23. Daugherty A, Whitman SC, (2003) Quantification of atherosclerosis in mice. Methods Mol Biol 209: 293-309.
24. Daugherty A, Rateri DL, (2005) Development of experimental designs for atherosclerosis studies in mice. Methods 36: 129-138.
25. Lu H, Balakrishnan A, Howatt DA, Wu C, Charnigo R, et al. (2012) Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis. Br J Pharmacol 165: 2000-2008.
26. Rateri DL, Howatt DA, Moorleghen JJ, Charnigo R, Cassis LA, et al. (2011) Prolonged infusion of angiotensin II in apoE(-/-) mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm. Am J Pathol 179: 1542-1548.
27. Dudley DT, Hubbell SE, Summerfelt RM, (1991) Characterization of angiotensin II (AT2) binding sites in R3T3 cells. Mol Pharmacol 40: 360-367.
28. Yayama K, Hiyoshi H, Imazu D, Okamoto H, (2006) Angiotensin II stimulates endothelial NO synthase phosphorylation in thoracic aorta of mice with abdominal aortic banding via type 2 receptor. Hypertension 48: 958-964.
29. Weiss D, Kools JJ, Taylor WR, (2001) Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice. Circulation 103: 448-454.
30. Bruemmer D, Collins AR, Noh G, Wang W, Territo M, et al. (2003) Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. J Clin Invest 112: 1318-1331.
31. Wang YX, Martin-McNulty B, Freay AD, Sukovich DA, Halks-Miller M, et al. (2001) Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice. Am J Pathol 159: 1455-1464.
32. Wang M, Lee E, Song W, Ricciotti E, Rader DJ, et al. (2008) Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation. Circulation 117: 1302-1309.
33. Okui S, Yamamoto H, Li W, Gamachi N, Fujita Y, et al. (2012) Cisplatin-induced acute renal failure in mice is mediated by chymase-activated angiotensin-aldosterone system and interleukin-18. Eur J Pharmacol 685: 149-155.
34. Tesanovic S, Vinh A, Gaspari TA, Casley D, Widdop RE, (2010) Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 30: 1606-1613.
35. Clere N, Corre I, Faure S, Guihot AL, Vessieres E, et al. (2010) Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis. Int J Cancer 127: 2279-2291.
36. Praddaude F, Cousins SW, Pecher C, Marin-Castano ME, (2009) Angiotensin II-induced hypertension regulates AT1 receptor subtypes and extracellular matrix turnover in mouse retinal pigment epithelium. Exp Eye Res 89: 109-118.
37. Tsutsumi Y, Matsubara H, Masaki H, Kurihara H, Murasawa S, et al. (1999) Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J. Clin. Invest. 104: 925-935.
38. Ruan X, Oliverio MI, Coffman TM, Arendshorst WJ, (1999) Renal vascular reactivity in mice: AngII-induced vasoconstriction in AT1A receptor null mice. J Am Soc Nephrol 10: 2620-2630.
39. Saraff K, Babamusta F, Cassis LA, Daugherty A, (2003) Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 23: 1621-1626.
40. Daugherty A, Cassis LA, Lu H, (2011) Complex pathologies of angiotensin II-induced abdominal aortic aneurysms. J Zhejiang Univ Sci B 12: 624-628.
41. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, et al. (2006) Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312: 117-121.
42. Habashi JP, Doyle JJ, Holm TM, Aziz H, Schoenhoff F, et al. (2011) Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science 332: 361-365.